Market Research Logo

Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Inovio Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Inovio Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Inovio Pharmaceuticals, Inc.
  • The report provides overview of Inovio Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Inovio Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Inovio Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Inovio Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Inovio Pharmaceuticals, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Inovio Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Inovio Pharmaceuticals, Inc. Snapshot
Inovio Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Inovio Pharmaceuticals, Inc. - Research and Development Overview
Key Therapeutic Areas
Inovio Pharmaceuticals, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Inovio Pharmaceuticals, Inc. - Pipeline Products Glance
Inovio Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Inovio Pharmaceuticals, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Inovio Pharmaceuticals, Inc. - Drug Profiles
VGX-3100
Product Description
Mechanism of Action
R&D Progress
INO-8000
Product Description
Mechanism of Action
R&D Progress
FVH-1
Product Description
Mechanism of Action
R&D Progress
influenza [strain A/H3N2] vaccine
Product Description
Mechanism of Action
R&D Progress
INO-1400
Product Description
Mechanism of Action
R&D Progress
INO-3106
Product Description
Mechanism of Action
R&D Progress
INO-3510
Product Description
Mechanism of Action
R&D Progress
INO-4212
Product Description
Mechanism of Action
R&D Progress
INO-4500
Product Description
Mechanism of Action
R&D Progress
INO-5150
Product Description
Mechanism of Action
R&D Progress
PENNVAX-B
Product Description
Mechanism of Action
R&D Progress
PENNVAX-G
Product Description
Mechanism of Action
R&D Progress
PENNVAX-GP
Product Description
Mechanism of Action
R&D Progress
VGX-3400X
Product Description
Mechanism of Action
R&D Progress
VRC-01
Product Description
Mechanism of Action
R&D Progress
chikungunya vaccine
Product Description
Mechanism of Action
R&D Progress
Clostridium difficile vaccine
Product Description
Mechanism of Action
R&D Progress
dengue [serotypes 1, 2, 3, 4] (tetravalent) vaccine
Product Description
Mechanism of Action
R&D Progress
Gene Therapy for Ebola Virus Infections
Product Description
Mechanism of Action
R&D Progress
influenza [strain A/H7N9] vaccine
Product Description
Mechanism of Action
R&D Progress
INO-5400
Product Description
Mechanism of Action
R&D Progress
MAV-12
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibodies to Inhibit Tyrosinase for Oncology and Immunology
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody for Chikungunya
Product Description
Mechanism of Action
R&D Progress
respiratory syncytial virus vaccine
Product Description
Mechanism of Action
R&D Progress
RSQ-15
Product Description
Mechanism of Action
R&D Progress
Vaccine for Cancer
Product Description
Mechanism of Action
R&D Progress
Vaccines for Neurological Disorders
Product Description
Mechanism of Action
R&D Progress
Inovio Pharmaceuticals, Inc. - Pipeline Analysis
Inovio Pharmaceuticals, Inc. - Pipeline Products by Target
Inovio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
Inovio Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates
Inovio Pharmaceuticals, Inc. - Dormant Projects
Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
mifepristone
VGX-410C
Inovio Pharmaceuticals, Inc. - Company Statement
Inovio Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Inovio Pharmaceuticals, Inc., Key Information
Inovio Pharmaceuticals, Inc., Key Facts
Inovio Pharmaceuticals, Inc. - Pipeline by Indication, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016
Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016
Inovio Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016
Inovio Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2016
Inovio Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016
Inovio Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016
Inovio Pharmaceuticals, Inc. - Phase II, 2016
Inovio Pharmaceuticals, Inc. - Phase I, 2016
Inovio Pharmaceuticals, Inc. - Preclinical, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Target, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016
Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016
Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016
Inovio Pharmaceuticals, Inc. - Dormant Developmental Projects,2016
Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016
Inovio Pharmaceuticals, Inc., Subsidiaries
List of Figures
Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016
Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016
Inovio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016
Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report